At LogiPharma USA 2026, Cold Chain Technologies' TJ Rizzo explains how gaps in end-to-end cold chain expertise create risk ...
Octapharma USA's Kerem Tokel explains how tariffs and DSCSA are affecting how stolen pharma loads are resold, and why partner ...
Global Benchmark for Efficient Drug Pricing (GLOBE) Model, CMS's most favored nation (MFN) pricing policy for Medicare Part B ...
According to Nitin Jayakrishnan, co-founder and CEO of Freehand, disruptions that pharmaceutical supply chains once treated ...
At LogiPharma USA 2026, the keynote panel on building a truly end-to-end supply chain centered on a familiar industry problem ...
Swisslog's Mark Beers discusses how software helps pharma supply chains adapt to shifting portfolios, strengthen inventory verification and build trust. As pharma portfolios shift toward biologics, ...
At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains. Supply chain ...
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation.
AI should not be framed as influencing prescribing; it can close the information-access gap by delivering brand-approved, ...
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation. According to Garrett Freeman, sales ...
At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance. As regulators sharpen their ...
McKesson's Chris Van Norman previews his LogiPharma USA keynote on demand signal sharing, AI, and precision distribution for targeted therapies. As therapies become more targeted and time-sensitive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results